IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Healthcare Value Capital, LLC

Q2 2017 Holdings

Filed 2017-08-10 | 17 holdings | $55.7K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Pfizer Inc(PFE)COM717081103$8.4K250,00015.1%
Novelion Therapeutics IncCOM NEW67001K202$7.7K831,44013.8%
Depomed IncCOM249908104$5.9K550,00010.6%
Gilead Sciences Inc(GILD)COM375558103$5.3K75,0009.5%
Proshares TRCallULTSH NASD BIOT74347B789$4.9K200,0008.7%
Gilead Sciences Inc(GILD)CallCOM375558103$4.2K60,0007.6%
Cryolife Inc(AORT)PutCOM228903100$4.0K200,0007.2%
Allergan PLCSHSG0177J108$3.6K15,0006.6%
Proshares TR IICallVIX SHORT TERM F74347W262$2.7K250,0004.8%
Teva Pharmaceutical Inds LTD(TEVA)SPONSORED ADR881624209$2.5K75,0004.5%
Amarin Corp PLCSPONS ADR NEW023111206$1.8K450,0003.3%
Fluidigm Corp del(LAB)COM34385P108$1.5K360,5002.6%
Depomed IncCallCOM249908104$1.1K100,0001.9%
Immunomedics Inc(IMMU)CallCOM452907108$883100,0001.6%
Proshares TRULTSH NASD BIOT74347B789$60625,0001.1%
Fluidigm Corp del(LAB)CallCOM34385P108$606150,0001.1%
Fibrocell Science IncCallCOM PAR315721308$4010,0000.1%